Biosimilars Treated Like Brand-Name Drugs for 340B Discounts

by Admin | April 1, 2015 2:58 pm

April 1, 2015—The Centers for Medicare & Medicaid Services announced a policy decision about Medicaid drug rebates this week that will result in safety-net healthcare providers getting the same 340B discount percentage on biosimilar medicines as they receive on brand-name drugs.  

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Source URL: https://340binformed.org/2015/04/biosimilars-treated-like-brand-name-drugs-for-340b-discounts/

---